155 related articles for article (PubMed ID: 12108951)
1. Rate limiting steps of AAV transduction and implications for human gene therapy.
Sanlioglu S; Monick MM; Luleci G; Hunninghake GW; Engelhardt JF
Curr Gene Ther; 2001 Jul; 1(2):137-47. PubMed ID: 12108951
[TBL] [Abstract][Full Text] [Related]
2. Intracellular trafficking of adeno-associated viral vectors.
Ding W; Zhang L; Yan Z; Engelhardt JF
Gene Ther; 2005 Jun; 12(11):873-80. PubMed ID: 15829993
[TBL] [Abstract][Full Text] [Related]
3. Intracellular transport of recombinant adeno-associated virus vectors.
Nonnenmacher M; Weber T
Gene Ther; 2012 Jun; 19(6):649-58. PubMed ID: 22357511
[TBL] [Abstract][Full Text] [Related]
4. Novel approaches to augment adeno-associated virus type-2 endocytosis and transduction.
Sanlioglu AD; Karacay B; Benson PK; Engelhardt JF; Sanlioglu S
Virus Res; 2004 Aug; 104(1):51-9. PubMed ID: 15177892
[TBL] [Abstract][Full Text] [Related]
5. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
Shi W; Arnold GS; Bartlett JS
Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
[TBL] [Abstract][Full Text] [Related]
6. Impaired nuclear transport and uncoating limit recombinant adeno-associated virus 2 vector-mediated transduction of primary murine hematopoietic cells.
Zhong L; Li W; Yang Z; Qing K; Tan M; Hansen J; Li Y; Chen L; Chan RJ; Bischof D; Maina N; Weigel-Kelley KA; Zhao W; Larsen SH; Yoder MC; Shou W; Srivastava A
Hum Gene Ther; 2004 Dec; 15(12):1207-18. PubMed ID: 15684697
[TBL] [Abstract][Full Text] [Related]
7. Adeno-Associated Virus (AAV) Gene Delivery: Dissecting Molecular Interactions upon Cell Entry.
Large EE; Silveria MA; Zane GM; Weerakoon O; Chapman MS
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372542
[TBL] [Abstract][Full Text] [Related]
8. Syntaxin 5-dependent retrograde transport to the trans-Golgi network is required for adeno-associated virus transduction.
Nonnenmacher ME; Cintrat JC; Gillet D; Weber T
J Virol; 2015 Feb; 89(3):1673-87. PubMed ID: 25410859
[TBL] [Abstract][Full Text] [Related]
9. Adeno-associated virus-based vectors in gene therapy.
Tal J
J Biomed Sci; 2000; 7(4):279-91. PubMed ID: 10895050
[TBL] [Abstract][Full Text] [Related]
10. Recombinant adeno-associated virus vectors for gene therapy.
Conlon TJ; Flotte TR
Expert Opin Biol Ther; 2004 Jul; 4(7):1093-101. PubMed ID: 15268676
[TBL] [Abstract][Full Text] [Related]
11. Cellular transduction mechanisms of adeno-associated viral vectors.
Berry GE; Asokan A
Curr Opin Virol; 2016 Dec; 21():54-60. PubMed ID: 27544821
[TBL] [Abstract][Full Text] [Related]
12. Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
Janelidze S; Nordström U; Kügler S; Brundin P
J Gene Med; 2014; 16(9-10):300-8. PubMed ID: 25303717
[TBL] [Abstract][Full Text] [Related]
13. Adeno-associated virus (AAV) serotypes 2, 4 and 5 display similar transduction profiles and penetrate solid tumor tissue in models of human glioma.
Thorsen F; Afione S; Huszthy PC; Tysnes BB; Svendsen A; Bjerkvig R; Kotin RM; Lønning PE; Hoover F
J Gene Med; 2006 Sep; 8(9):1131-40. PubMed ID: 16810631
[TBL] [Abstract][Full Text] [Related]
14. Existence of transient functional double-stranded DNA intermediates during recombinant AAV transduction.
Wang J; Xie J; Lu H; Chen L; Hauck B; Samulski RJ; Xiao W
Proc Natl Acad Sci U S A; 2007 Aug; 104(32):13104-9. PubMed ID: 17664425
[TBL] [Abstract][Full Text] [Related]
15. Identification of host essential factors for recombinant AAV transduction of the polarized human airway epithelium.
Hao S; Zhang X; Ning K; Feng Z; Park SY; Aksu Kuz C; McFarlin S; Richart D; Cheng F; Zhang EY; Zhang-Chen A; Yan Z; Qiu J
J Virol; 2023 Dec; 97(12):e0133023. PubMed ID: 37966249
[TBL] [Abstract][Full Text] [Related]
16. Obstacles to human hematopoietic stem cell transduction by recombinant adeno-associated virus 2 vectors.
Srivastava A
J Cell Biochem Suppl; 2002; 38():39-45. PubMed ID: 12046848
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy using adeno-associated virus vectors.
Daya S; Berns KI
Clin Microbiol Rev; 2008 Oct; 21(4):583-93. PubMed ID: 18854481
[TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of Small Molecules That Enhance Recombinant Adeno-associated Virus Transduction following High-Throughput Screens.
Nicolson SC; Li C; Hirsch ML; Setola V; Samulski RJ
J Virol; 2016 Aug; 90(16):7019-7031. PubMed ID: 27147738
[TBL] [Abstract][Full Text] [Related]
19. Genomic stability of self-complementary adeno-associated virus 2 during early stages of transduction in mouse muscle in vivo.
Ren C; Kumar S; Shaw DR; Ponnazhagan S
Hum Gene Ther; 2005 Sep; 16(9):1047-57. PubMed ID: 16149903
[TBL] [Abstract][Full Text] [Related]
20. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.
Hirsch ML; Wolf SJ; Samulski RJ
Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
